Funding Received
$1.3 Million in 1 Round from 1 Investor
Most Recent Funding
$1.3 Million Seed on February 18, 2013
Description:
Helmedix is a biopharmaceutical company that develops therapeutic peptide drugs for autoimmune diseases.

Detailed Description

Update

Helmedix Pty. Ltd. operates as a biopharmaceutical company which develops therapeutic peptide drugs for autoimmune diseases.

Funding Rounds (1) - $1.3M

Update

Investors (1)

Update